Aminobenzoic acids and derivatives
Chemscene Coumarin-6-sulfonyl chloride | 1g | CS-0009933 | 95% | 10543-42-7 | MFCD01941320 | 244 66 | C9H5ClO4S
Chemscene | Coumarin-6-sulfonyl chloride | 1g | CS-0009933 | 95% | 10543-42-7 | MFCD01941320 | 244 66 | C9H5ClO4S
Chemscene 1 4-Dibromobenzene | 1kg | CS-0000003 | 98% | 106-37-6 | MFCD00000089 | 235 91 | C6H4Br2
Chemscene | 1 4-Dibromobenzene | 1kg | CS-0000003 | 98% | 106-37-6 | MFCD00000089 | 235 91 | C6H4Br2
Chemscene Z-Tyr-OH | 500g | CS-W007931 | 98% | 1164-16-5 | MFCD00037180 | 315 32 | C17H17NO5
Chemscene | Z-Tyr-OH | 500g | CS-W007931 | 98% | 1164-16-5 | MFCD00037180 | 315 32 | C17H17NO5
Chemscene Butylated hydroxytoluene | 100g | CS-W020053 | 98% | 128-37-0 | MFCD00011644 | 220 36 | C15H24O
Chemscene | Butylated hydroxytoluene | 100g | CS-W020053 | 98% | 128-37-0 | MFCD00011644 | 220 36 | C15H24O
Chemscene 6-Chloro-5-(2-chloroethyl)oxindole | 25g | CS-W010382 | 97% | 118289-55-7 | MFCD03411598 | 230 09 | C10H9Cl2NO
Chemscene | 6-Chloro-5-(2-chloroethyl)oxindole | 25g | CS-W010382 | 97% | 118289-55-7 | MFCD03411598 | 230 09 | C10H9Cl2NO
Chemscene 2-Methyl-3-phenylacrylaldehyde | 5g | CS-W016354 | 96% | 101-39-3 | MFCD00006976 | 146 19 | C10H10O
Chemscene | 2-Methyl-3-phenylacrylaldehyde | 5g | CS-W016354 | 96% | 101-39-3 | MFCD00006976 | 146 19 | C10H10O
Chemscene 2-Fluoro-3-(trifluoromethyl)benzoic acid | 25g | CS-0007568 | 98% | 115029-22-6 | MFCD00040980 | 208 11 | C8H4F4O2
Chemscene | 2-Fluoro-3-(trifluoromethyl)benzoic acid | 25g | CS-0007568 | 98% | 115029-22-6 | MFCD00040980 | 208 11 | C8H4F4O2
Medchemexpress LLC Pomalidomide-amino-PEG5-NH2 hydrochloride | 2421217-05-0 | MFCD01304495 | 99.6% | C25H35ClN4O10 | 10MG
Pomalidomide-amino-PEG5-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate combining a pomalidomide-derived cereblon ligand with a PEG5 amine linker. Supplied as the hydrochloride salt, it is intended as a research building block for proteolysis targeting chimera (PROTAC) design and ligand-linker conjugation studies.
- Suitable for PROTAC synthesis and E3 ligase targeting.
- Hydrochloride salt improves handling and stability.
- High purity appropriate for research applications.
- Soluble in DMSO at high concentration; ultrasonic assistance recommended.
- Stable when stored sealed at 4°C; defined solvent storage conditions extend shelf life.
- Supplied as a solid for convenient weighing and storage.
Medchemexpress LLC Tauro-obeticholic acid | 863239-61-6 | MFCD33402170 | 98.2% | C28H49NO6S | 10MG
Tauro-obeticholic acid is the taurine-conjugated active metabolite of obeticholic acid and functions as an agonist of the farnesoid X receptor (FXR). It is supplied for research use in studies of bile acid signaling, FXR-mediated pharmacology, and metabolic pathways; typical specifications include formula C28H49NO6S, MW 527.76, and high purity.
- Acts as a farnesoid X receptor (FXR) agonist useful for studying bile acid signaling.
- Taurine-conjugated metabolite of obeticholic acid.
- Supplied with high purity suitable for analytical and pharmacology studies.
- Available in multiple small-scale package sizes for research workflows.
- Soluble in common organic solvents and DMSO for assay preparation.